Janus kinase inhibitors
Clinical trials for Janus kinase inhibitors explained in plain language.
Never miss a new study
Get alerted when new Janus kinase inhibitors trials appear
Sign up with your email to follow new studies for Janus kinase inhibitors, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a JAK inhibitor boost remission in IgG4-Related disease?
Disease control CompletedResearchers are testing whether adding tofacitinib to prednisone works better than prednisone alone for people with active IgG4-related disease. The trial enrolls 58 adults with active disease and assigns them to either tofacitinib plus prednisone or prednisone alone. The main go…
Matched conditions: JANUS KINASE INHIBITORS
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New study tracks Real-World use of eczema drug abrocitinib
Disease control CompletedThis study follows 200 people aged 12 and older with moderate-to-severe eczema who are starting a new prescription of abrocitinib. Researchers will track how much their skin improves over 12 months using standard eczema severity scores. The goal is to see how well the drug works …
Matched conditions: JANUS KINASE INHIBITORS
Sponsor: Pfizer • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC